Skip to menu Skip to content Skip to footer

HONEYPOT (A randomised controlled trial of exit site application of Medihoney Antibacterial Wound Gel for the preventation of catheter-associated infections in peritoneal dialysis patients) (2007-2010)

Abstract

That in peritoneal dialysis patients, the daily exit site application of standardised antibacterial honey (in addition to daily cleansing) will more effectively prevent exit site infections, tunnel infections and peritonitis associated with peritoneal dialysis (PD) catheters than the current standard treatment of intranasal mupirocin prophlaxis for nasal staphylococcal carriers.

Experts

Professor David Johnson

Affiliate of Centre for Health Services Research
Centre for Health Services Research
Faculty of Health, Medicine and Behavioural Sciences
NHMRC Leadership Fellow
Centre for Health Services Research
Faculty of Health, Medicine and Behavioural Sciences
David Johnson
David Johnson